It’s A Whole New World: Navigating Therapeutic Options for Endometrial Cancer

Поделиться
HTML-код
  • Опубликовано: 29 ноя 2024

Комментарии • 2

  • @melaniepitt4295
    @melaniepitt4295 5 месяцев назад +1

    As a recurrent endometrial cancer survivor (pMMR) currently trying to maintain an active lifestyle with side effects of pembrolizumab/lenvatinib treatment, I am encouraged by your contributors knowledge and dedication to research. Unfortunately, I have no scientific training so will be studying the transcript over and over. Many thanks.

    • @alexlin6287
      @alexlin6287 5 месяцев назад

      Try selinexor clinical trials if your p53 is unmutated. Selinexor is a weekly oral drug used for Maintenance therapy in wt p53 ec patients. Especially for pMMR population, it shows 39.5 months vs 5.9 months PFS in recent published literature.